FTDI
TEVA icon

First Trust Direct Indexing’s Teva Pharmaceuticals TEVA Stock Holding History

First Trust Direct Indexing’s Portfolio TEVA Stock Details TEVA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q4 		– Sell
-10,255
Closed -$185K – 826
2024
Q3 		$185K Sell
10,255
-2,409
-19% -$42.2K 0.01% 929
2024
Q2 		$206K Buy
+12,664
New +$195K 0.01% 825

Other funds holding TEVA

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
CI
Clal Insurance Tel-Aviv, Israel $16.6B AUM 68.34% 1-Year Est. Return
IAM
Ion Asset Management Herzliya, Israel $911M AUM 24.97% 1-Year Est. Return
MMH
Menora Mivtachim Holdings Ramat Gan, Israel $21.1B AUM 40.03% 1-Year Est. Return
LIM
Lingotto Investment Management London, United Kingdom $5.06B AUM 91.14% 1-Year Est. Return
MIFH
Migdal Insurance & Financial Holdings Petach Tikva, Israel $11.5B AUM 52.5% 1-Year Est. Return
PF
Phoenix Financial Givatayim, Israel $10.5B AUM 49.21% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
RCMNY
Rubric Capital Management (New York) New York $9.44B AUM 68.42% 1-Year Est. Return

First Trust Direct Indexing's TEVA Position: Q4 2024 in Review

First Trust Direct Indexing sold out of Teva Pharmaceuticals (TEVA) in Q4 2024, closing a stake of 10,255 shares — an estimated $185K sold.

First Trust Direct Indexing first reported a position in TEVA in Q2 2024 and held it in 2 quarters. The position peaked at $206K in Q2 2024. 583 funds tracked by Wall St. Rank hold TEVA as of Q4 2024.

  • First Trust Direct Indexing reported no remaining Teva Pharmaceuticals position as of Q4 2024 after selling out during the quarter.
  • First Trust Direct Indexing sold 10,255 Teva Pharmaceuticals shares in Q4 2024, an estimated $185K.
  • First Trust Direct Indexing first reported a position in Teva Pharmaceuticals in Q2 2024 and held it in 2 quarters.
  • First Trust Direct Indexing's Teva Pharmaceuticals position peaked at $206K in Q2 2024.
  • 583 funds tracked by Wall St. Rank held Teva Pharmaceuticals as of Q4 2024.

Based on First Trust Direct Indexing's 13F filing for Q4 2024.